Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter Topoisomerase II alpha Antikörper (AA 1352-1493)

Dieser Anti-Topoisomerase II alpha Antikörper ist ein Maus Monoklonal Antikörper zur Detektion von Topoisomerase II alpha in WB und IHC (f). Geeignet für Human.
Produktnummer ABIN7127009

Kurzübersicht für Rekombinanter Topoisomerase II alpha Antikörper (AA 1352-1493) (ABIN7127009)

Target

Alle Topoisomerase II alpha (TOP2A) Antikörper anzeigen
Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 151
  • 72
  • 41
  • 5
  • 5
  • 3
  • 3
  • 3
  • 1
Human

Wirt

  • 114
  • 38
Maus

Klonalität

  • 92
  • 60
Monoklonal

Konjugat

  • 79
  • 10
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Topoisomerase II alpha Antikörper ist unkonjugiert

Applikation

  • 109
  • 70
  • 52
  • 47
  • 24
  • 23
  • 19
  • 8
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Bindungsspezifität

    • 17
    • 15
    • 10
    • 10
    • 8
    • 7
    • 7
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1352-1493

    Spezifität

    It recognizes a 170 kDa protein, which is identified as topoisomerase IIi±. It shows no cross-reaction with Topoisomerase II i² or I. Topo II i± plays important roles in synthesis and transcription of DNA as well as chromosomal segregation during mitosis. It is reported to be a sensitive and specific marker of late S-, G2- & M-phases in transformed and developmentally regulated normal cells. Topo II i± is also implicated in drug resistance of tumor cells and has been shown to be over-expressed in many human cancers. Decreased expression of Topo IIa is the predominant mechanism of resistance to several chemotherapeutic agents.

    Kreuzreaktivität (Details)

    Human. Mouse.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant human Topoisomerase II alpha fragment (aa1352-1493)

    Isotyp

    IgG2a
  • Applikationshinweise

    Known_Application: Western Blot (1-2 μg/mL),Immunohistochemistry (Formalin-fixed) (0.5-1 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa or Jurkat cells. Human lymph node or tonsil.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

    Andere Bezeichnung

    TOP2A

    Hintergrund

    ATP hydrolyzing DNA topoisomerase II alfa, DNA gyrase, DNA topoisomerase (ATP hydrolyzing), DNA topoisomerase 2 alpha, DNA topoisomerase II 170kD, DNA topoisomerase II alpha, DNA Topoisomerase2, TOP2A, Topoisomerase DNA II alpha 170 kDa, TP2A,Topoisomerase II alpha (Proliferation & Drug-Resistance Marker)
    Cellular localisation: Nuclear

    Molekulargewicht

    170kDa

    Gen-ID

    7153, 156346

    UniProt

    P11388

    Pathways

    Zellzyklus, Mitotic G1-G1/S Phases
Sie sind hier:
Chat with us!